trending Market Intelligence /marketintelligence/en/news-insights/trending/McdVpZXnQw6ig0t9GT8rGQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Tracking mosquito viruses, CRISPR-ing mice tumors; FDA shutdown may enter 2019

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Tracking mosquito viruses, CRISPR-ing mice tumors; FDA shutdown may enter 2019

Here are the editors' top picks for the week ended Dec. 28.

Of Mice Not Men: Tracking mosquito viruses; CRISPR-ing obesity and tumors

In this week's column, scientists looked to mosquitoes' stomachs to track the transmission of viruses, an Alzheimer's protein was found in contaminated brain tissue extracts, and CRISPR mitigated obesity and chemotherapy resistance in mice.

Capitol Checkup: Both sides want speedy ACA appeal; FDA shutdown may go to 2019

Both sides in the legal battle over the constitutionality of the Affordable Care Act want the case to promptly move forward to an appeal; meanwhile, the head of the U.S. Food and Drug Administration tried to reassure Americans during the shutdown.

EU agency recommends 84 new medicines in 2018; reviews heart drugs with impurity

The European Medicines Agency recommended 84 new medicines for marketing authorization in 2018 and initiated the review of a hypertension drug after finding traces of a potential cancer-causing compound.

Junshi stock surges to HK$23.75 per share in Hong Kong debut

The Shanghai-based company in December received approval to produce China's first homemade PD-1 class of checkpoint inhibitors.

Medicaid agency approves work requirement programs for Michigan, Maine

The Centers for Medicare and Medicaid Services has approved work requirement waivers for Maine and Michigan, increasing the number of states to have work requirement programs approved to seven.

Medicare agency finalizes changes to shared savings program for provider groups

The Centers for Medicare and Medicaid Services finalized the agency's restructuring of the accountable care organization shared savings program. The agency also increased certain savings rates from their levels in the August proposed rule.

US price watchdog: Novartis' gene therapy is better value than Biogen rival

The Institute for Clinical and Economic Review has found that a new gene therapy from Novartis AG is more cost-effective than Biogen Inc.'s Spinraza in treating a rare, debilitating infant disease called spinal muscular atrophy.